Genmab — Marts 2021
-
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma
-
God morgen.

-
-
Ikke noget særligt, Darzalex bruges i de føtste linier af behandlingen, CAR-T kommer først i betagtning, når de gængse behandlinsformer ikke mere virker.
-
-
Langers Skarpe: Så er der dømt aktierally:https://www.proinvestor.com/investornyt/673561/langers-skarpe-sa-er-der-domt-aktierally
-
God morgen.

-
Asien: Stigninger næsten overalt efter Wall Street rekorder https://www.proinvestor.com/investornyt/673564/asien-stigninger-naesten-overalt-efter-wall-street-rekorder
-
Mandagens aviser med Danske Bank, Netcompany og Jyske Bank
https://www.proinvestor.com/investornyt/673565/mandagens-aviser-med-danske-bank-netcompany-og-jyske-bank
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind